HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shoshana Yakar Selected Research

Obesity

1/2010Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis.
1/2009Obesity provides a permissive milieu in inflammation-associated carcinogenesis: analysis of insulin and IGF pathways.
12/2006Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shoshana Yakar Research Topics

Disease

29Neoplasms (Cancer)
12/2021 - 02/2002
23Insulin Resistance
12/2021 - 06/2003
13Type 2 Diabetes Mellitus (MODY)
01/2023 - 07/2003
9Inflammation (Inflammations)
01/2024 - 01/2009
9Neoplasm Metastasis (Metastasis)
03/2018 - 02/2002
8Breast Neoplasms (Breast Cancer)
06/2013 - 08/2003
6Hyperglycemia
05/2021 - 06/2003
6Body Weight (Weight, Body)
01/2020 - 04/2010
6Hyperinsulinism (Hyperinsulinemia)
01/2017 - 11/2004
5Laron Syndrome (Syndrome, Laron)
12/2021 - 07/2013
4Bone Resorption
01/2018 - 02/2010
4Osteoporosis
10/2013 - 09/2002
4Carcinogenesis
12/2009 - 08/2005
3Dwarfism
12/2021 - 07/2019
3Non-alcoholic Fatty Liver Disease
01/2021 - 05/2013
3Metabolic Bone Diseases (Osteopenia)
12/2020 - 03/2005
3Obesity
01/2010 - 12/2006
2Insulin-Like Growth Factor I Deficiency
12/2021 - 01/2019
2Endometrial Neoplasms (Endometrial Cancer)
12/2021 - 07/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 11/2017
2Carcinoma (Carcinomatosis)
03/2018 - 01/2012
2Fatty Liver
11/2017 - 05/2013
2Prostatic Neoplasms (Prostate Cancer)
12/2016 - 05/2008
2Growth Disorders
04/2016 - 03/2014
2Starvation
02/2012 - 06/2004
2Hyperplasia
06/2011 - 06/2003
2Colonic Neoplasms (Colon Cancer)
12/2009 - 02/2002
2Adenocarcinoma
05/2008 - 02/2002
1Mitochondrial Diseases (Mitochondrial Disease)
03/2024
1Arthralgia (Joint Pain)
01/2023
1Joint Diseases (Joint Disease)
01/2023
1Acromegaly
11/2022
1Osteogenesis Imperfecta (Lobstein Disease)
12/2021
1Uterine Neoplasms (Uterine Cancer)
12/2021
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2021
1Ovarian Epithelial Carcinoma
01/2021
1Lipodystrophy
12/2020
1Arthritis (Polyarthritis)
12/2020
1Lewis Lung Carcinoma
03/2018
1Hepatitis
01/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2018
1Liver Diseases (Liver Disease)
01/2018
1Fibrosis (Cirrhosis)
11/2017
1Microcephaly
01/2016
1Fatigue
01/2016
1Alzheimer Disease (Alzheimer's Disease)
08/2015
1Reperfusion Injury
08/2015
1Myocardial Ischemia (Ischemic Heart Diseases)
08/2015

Drug/Important Bio-Agent (IBA)

37Insulin-Like Growth Factor I (IGF-1)IBA
01/2020 - 02/2002
23Insulin (Novolin)FDA Link
12/2021 - 07/2003
12Growth Hormone (Somatotropin)IBA
01/2023 - 10/2003
12Glucose (Dextrose)FDA LinkGeneric
01/2018 - 06/2003
10IGF Type 1 Receptor (IGF 1 Receptor)IBA
07/2009 - 07/2003
9Insulin-Like PeptidesIBA
01/2021 - 08/2005
6Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2002
6LipidsIBA
11/2017 - 07/2003
5Messenger RNA (mRNA)IBA
12/2021 - 10/2003
5LigandsIBA
03/2018 - 08/2005
4Somatotropin Receptors (Growth Hormone Receptor)IBA
12/2021 - 06/2011
4Insulin-Like Growth Factor Binding Protein 3IBA
01/2019 - 09/2002
4Triglycerides (Triacylglycerol)IBA
08/2015 - 10/2003
3CytokinesIBA
01/2017 - 01/2009
3Estrogens (Estrogen)FDA Link
01/2016 - 12/2006
3AcidsIBA
01/2016 - 10/2003
3Tumor Viral Antigens (Large T Antigen)IBA
12/2010 - 08/2003
2InflammasomesIBA
01/2024 - 12/2023
2Matrix Metalloproteinase 13IBA
01/2024 - 12/2023
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2024 - 12/2023
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2018 - 02/2002
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 08/2015
2OsteoprotegerinIBA
01/2017 - 12/2016
2Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2016 - 08/2005
2Insulin-Like Growth Factor Binding ProteinsIBA
01/2016 - 08/2005
2Insulin ReceptorIBA
06/2013 - 09/2005
2Transcription Factors (Transcription Factor)IBA
05/2013 - 01/2012
2CarbohydratesIBA
01/2012 - 12/2010
2Blood Glucose (Blood Sugar)IBA
03/2007 - 01/2004
2Hormones (Hormone)IBA
12/2006 - 11/2005
1Methylene Blue (Methylthioninium Chloride)FDA Link
03/2024
1mitoquinoneIBA
03/2024
1CanagliflozinIBA
01/2023
1Metformin (Glucophage)FDA LinkGeneric
01/2023
1ORALIT (ORS)IBA
12/2021
1Odorant Receptors (Odorant Receptor)IBA
12/2021
1CollagenIBA
12/2020
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
12/2020
1Prolactin Receptors (Prolactin Receptor)IBA
01/2020
1ArginaseIBA
03/2018
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2018
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2018
1Parathyroid Hormone (Parathormone)IBA
01/2017
1prostatic acid phosphataseIBA
12/2016
1RANK LigandIBA
12/2016
1Silver Sulfadiazine (SSD)FDA LinkGeneric
04/2016
1Metalloproteases (Metalloproteinases)IBA
01/2016
1CaspasesIBA
01/2016
1Blood Proteins (Serum Proteins)IBA
01/2016
1humaninIBA
08/2015
1Peptides (Polypeptides)IBA
08/2015

Therapy/Procedure

8Therapeutics
01/2023 - 09/2005